Comparative deep sequencing analysis of five MYCN-amplified NB tumors versus matched normal tissues revealed 2242 significantly downregulated circRNAs, among which three tumor-suppressive circRNAs exhibited particularly promising therapeutic potential. The gene discussed is MYCN; the disease is neuroblastoma.